KP Tissue Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	8.5	2.43	-4.94	-10.25	1.24
Loss (Gain) From Sale of Investments	0.66	0.5	0.13	4.46	5
Loss (Gain) on Equity Investments	-9.17	-2.99	0.7	8.09	-6.13
Other Operating Activities	-	0.65	3.82	-2.22	-0.35
Change in Accounts Receivable	-	-	-	-	0.02
Change in Accounts Payable	-	-0.6	0.29	-0.08	0.21
Investment in Securities	-	-	-	6.62	5.56
Other Investing Activities	6.96	6.97	6.98	-	-
Investing Cash Flow	6.96	6.97	6.98	6.62	5.56
Common Dividends Paid	-6.96	-6.97	-6.98	-6.62	-5.56
Financing Cash Flow	-6.96	-6.97	-6.98	-6.62	-5.56
Cash Income Tax Paid	-	-0.6	0.29	-0.08	2.28
Change in Working Capital	-	-0.6	0.29	-0.08	0.23

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.